1. |
Jouneau S, Ménard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology, 2020, 25(8): 816-826.
|
2. |
Asai N, Motojima S, Ohkuni Y, et al. Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia. Respir Investig, 2022, 60(4): 522-530.
|
3. |
Cañas-Arboleda A, Hernández-Flórez C, Garzón J, et al. Colonization by Pneumocystis jirovecii in patients with chronic obstructive pulmonary disease: association with exacerbations and lung function status. Braz J Infect Dis, 2019, 23(5): 352-357.
|
4. |
Vera C, Rueda ZV. Transmission and colonization of Pneumocystis jirovecii. J Fungi, 2021, 7(11): 979.
|
5. |
Xue T, Ma Z, Liu F, et al. Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay. BMC Pulm Med, 2020, 20(1): 70.
|
6. |
Gingerich AD, Norris KA, Mousa JJ. Pneumocystis pneumonia: immunity, vaccines, and treatments. Pathogens, 2021, 10(2): 236.
|
7. |
Kumar A, Abdelmalak B, Inoue Y, et al. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet Respir Med, 2018, 6(7): 554-565.
|
8. |
Wang YQ, Zhou XY, Saimi M, et al. Risk factors of mortality from Pneumocystis pneumonia in non-HIV patients: a meta-analysis. Front Public Health, 2021, 9: 680108.
|
9. |
Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia. JAMA, 2020, 323(9): e45-e67.
|
10. |
Ghembaza A, Vautier M, Cacoub P, et al. Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases. Chest, 2020, 158(6): 2323-2332.
|
11. |
Shi SY, Zou RY, Chen LL, et al. Quantitative chest CT assessment of pulmonary alveolar proteinosis with deep learning: a real-world longitudinal study. Quant Imaging Med Surg, 2022, 12(12): 5394-5403.
|
12. |
Riley L, Wang T, Ataya A. Pulmonary alveolar proteinosis (PAP). Am J Respir Crit Care Med, 2019, 200(8): 16-17.
|
13. |
Zhang DM, Tian XL, Feng RE, et al. Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review). BMC Pulm Med, 2018, 18(1): 15.
|
14. |
Yan L, Wang Z, Zhao J, et al. Images: Secondary pulmonary alveolar proteinosis in brucellosis. Pulmonology, 2023, 29(4): 351-352.
|
15. |
Vidal S, de la Horra C, Martín J, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect, 2006, 12(3): 231-235.
|
16. |
Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest, 2021, 131(15): e150473.
|
17. |
Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev, 2012, 25(2): 297-317.
|
18. |
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med, 2002, 166(2): 215-235.
|
19. |
Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med, 2008, 177(7): 752-762.
|
20. |
Kho SS, Ganapaty S, Omar N, et al. Opportunistic actinomycosis in pulmonary alveolar proteinosis. Thorax, 2022, 77(8): 842-843.
|
21. |
Le Gal S, Bonnet P, Huguenin A, et al. The shift from pulmonary colonization to Pneumocystis pneumonia. Med Mycol, 2020, 59(5): 510-513.
|
22. |
Costabel U, Nakata K. Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune? Am J Respir Crit Care Med, 2010, 181(5): 427-428.
|
23. |
Fishman JA, Gans H, the AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant, 2019, 33(9): e13587.
|
24. |
Maskell NA, Waine DJ, Lindley A, et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax, 2003, 58(7): 594-597.
|